Ascentage Pharma Group International

AAPG · HONG

$15.44+$0.52 (+3.49%)TodayMarket closed · Oct 23, 7:30 PM ET

Prev close $14.92

Latest news

NewsOct 16, 1:52 PM ETVandana Singh
Ascentage Pharma Stock Could More Than Double: Analyst
NewsOct 7, 8:02 AM ETAvi Kapoor
Constellation Brands, Caribou Biosciences And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
NewsOct 2, 8:02 AM ETAvi Kapoor
Nike Posts Mixed Q1 Results, Joins Mangoceuticals And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
NewsAug 21, 2:07 AM ET
Transcript: Ascentage Pharma Group H1 2026 Earnings Conference Call
Press releaseAug 19, 7:00 PM ETGlobe Newswire
Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates
Press releaseAug 5, 9:07 AM ETGlobe Newswire
CORRECTION: Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026
NewsApr 9, 8:08 AM ETAvi Kapoor
Applied Digital, Simply Good Foods And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
NewsApr 1, 8:05 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
NewsApr 1, 5:27 AM ETAvi Kapoor
Why nCino Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Press releaseMar 25, 7:00 PM ETGlobe Newswire
Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates
NewsMar 25, 7:11 AM ET
Earnings Scheduled For March 25, 2026
Press releaseMar 11, 8:00 AM ETGlobe Newswire
Ascentage Pharma to Report Full Year 2025 Unaudited Financial Results and Provide Business Updates on March 25, 2026
NewsJan 7, 10:03 AM ETAvi Kapoor
Monte Rosa Therapeutics, Ventyx Biosciences, United Microelectronics And Other Big Stocks Moving Higher On Wednesday
NewsDec 23, 10:15 AM ETAvi Kapoor
Novo Nordisk, Sable Offshore, StoneCo And Other Big Stocks Moving Higher On Tuesday
Press releaseDec 1, 8:00 AM ETGlobe Newswire
Ascentage Pharma to Host Webcast Highlighting Key Data from ASH 2025
Press releaseAug 25, 8:00 AM ETGlobe Newswire
Ascentage Pharma to Participate in Three Upcoming Investor Conferences in September 2025
Press releaseAug 20, 7:57 PM ETGlobe Newswire
Ascentage Pharma Reports 2025 Interim Unaudited Six Months Financial Results and Business Updates
NewsAug 20, 4:32 AM ET
Earnings Scheduled For August 20, 2025
Press releaseAug 7, 8:00 AM ETGlobe Newswire
Ascentage Pharma to Report 2025 Six Month Interim Results and Provide Corporate Update on August 20, 2025
NewsJul 8, 6:24 AM ETRishabh Mishra
US Stocks Likely To Open Mixed As Trump Issues Tariff Letters: Experts Peg AI Investments As 'Durable Drivers Of Returns'
NewsMay 27, 8:13 AM ETAvi Kapoor
PDD Holdings Posts Weak Results, Joins EHang Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
NewsMar 27, 3:04 PM ETVandana Singh
Chinese Biotech Ascentage Pharma's Valuation Driven By Late-Stage De-Risked Assets: JPMorgan
Press releaseMar 27, 7:00 AM ETGlobe Newswire
Ascentage Pharma Reports Full Year 2024 Unaudited Financial Results and Business Updates
Press releaseMar 12, 8:46 AM ETGlobe Newswire
Ascentage Pharma to Report Full Year 2024 Financial Results and Provide Corporate Update on March 27, 2025
Press releaseMar 5, 6:00 PM ETGlobe Newswire
Olverembatinib Granted Breakthrough Therapy Designation for the Treatment of Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Ascentage Pharma Stock Could More Than Double: Analyst

Constellation Brands, Caribou Biosciences And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

Nike Posts Mixed Q1 Results, Joins Mangoceuticals And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

Transcript: Ascentage Pharma Group H1 2026 Earnings Conference Call

Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates

CORRECTION: Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026

Applied Digital, Simply Good Foods And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Why nCino Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket

Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates

Earnings Scheduled For March 25, 2026

Ascentage Pharma to Report Full Year 2025 Unaudited Financial Results and Provide Business Updates on March 25, 2026

Monte Rosa Therapeutics, Ventyx Biosciences, United Microelectronics And Other Big Stocks Moving Higher On Wednesday

Novo Nordisk, Sable Offshore, StoneCo And Other Big Stocks Moving Higher On Tuesday

Ascentage Pharma to Host Webcast Highlighting Key Data from ASH 2025

Ascentage Pharma to Participate in Three Upcoming Investor Conferences in September 2025

Ascentage Pharma Reports 2025 Interim Unaudited Six Months Financial Results and Business Updates

Earnings Scheduled For August 20, 2025

Ascentage Pharma to Report 2025 Six Month Interim Results and Provide Corporate Update on August 20, 2025

US Stocks Likely To Open Mixed As Trump Issues Tariff Letters: Experts Peg AI Investments As 'Durable Drivers Of Returns'

PDD Holdings Posts Weak Results, Joins EHang Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Chinese Biotech Ascentage Pharma's Valuation Driven By Late-Stage De-Risked Assets: JPMorgan

Ascentage Pharma Reports Full Year 2024 Unaudited Financial Results and Business Updates

Ascentage Pharma to Report Full Year 2024 Financial Results and Provide Corporate Update on March 27, 2025

Olverembatinib Granted Breakthrough Therapy Designation for the Treatment of Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)